Skip to content
10-Q

Quarterly Report

THERAGENICS CORP

0001188112-13-001489

← back to feed
Filed
May 13, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · May 6, 2013 31.06M sh
Shares Diluted Q1 2013 · Mar 31, 2013 29.07M sh
Shares Diluted Q1 2013 · Mar 31, 2012 33.94M sh
Capex Q1 2013 · Mar 31, 2013 $527K
Capex Q1 2013 · Mar 31, 2012 $329K
Long Term Debt Q1 2013 · Mar 31, 2013 $22M
Long Term Debt Q1 2013 · Dec 31, 2012 $22M
Cash And Equivalents Q1 2013 · Mar 31, 2013 $15.77M
Cash And Equivalents Q1 2013 · Dec 31, 2012 $23.59M
Cash And Equivalents Q1 2013 · Mar 31, 2012 $26.82M
Cash And Equivalents Q1 2013 · Dec 31, 2011 $29.55M
Stockholders Equity Q1 2013 · Mar 31, 2013 $77.19M
Stockholders Equity Q1 2013 · Dec 31, 2012 $76.93M
Current Liabilities Q1 2013 · Mar 31, 2013 $4.76M
Current Liabilities Q1 2013 · Dec 31, 2012 $5.57M
Total Liabilities Q1 2013 · Mar 31, 2013 $27.94M
Total Liabilities Q1 2013 · Dec 31, 2012 $28.8M
Current Assets Q1 2013 · Mar 31, 2013 $62.02M
Current Assets Q1 2013 · Dec 31, 2012 $61.55M
Total Assets Q1 2013 · Mar 31, 2013 $105.13M
Total Assets Q1 2013 · Dec 31, 2012 $105.73M
Eps Diluted Q1 2013 · Mar 31, 2013 $0.00
Eps Diluted Q1 2013 · Mar 31, 2012 $0.03
Eps Basic Q1 2013 · Mar 31, 2013 $0.00
Eps Basic Q1 2013 · Mar 31, 2012 $0.03
Sga Expense Q1 2013 · Mar 31, 2013 $5.68M
Sga Expense Q1 2013 · Mar 31, 2012 $5.9M
Rd Expense Q1 2013 · Mar 31, 2013 $280K
Rd Expense Q1 2013 · Mar 31, 2012 $277K
Net Income Q1 2013 · Mar 31, 2013 −$34K
Net Income Q1 2013 · Mar 31, 2012 $934K
Operating Income Q1 2013 · Mar 31, 2013 $17K
Operating Income Q1 2013 · Mar 31, 2012 $1.58M
Gross Profit Q1 2013 · Mar 31, 2013 $7.03M
Gross Profit Q1 2013 · Mar 31, 2012 $8.61M
Cost Of Revenue Q1 2013 · Mar 31, 2013 $12.85M
Cost Of Revenue Q1 2013 · Mar 31, 2012 $12.97M